Company Overview of CellAct Pharma GmbH
CellAct Pharma GmbH, a biotechnology company, engages in the development of therapeutics for the treatment of cancers and inflammatory diseases. The company develops drug candidates that target and modulate human molecules which have specific functions in tumour growth and immune response; and antibodies against surface molecules in lymphocytes to treat cancer and inflammation. It focuses on developing drugs for various diseases, including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, transplant rejection, lymphomas, and leukemia. CellAct Pharma GmbH is based in Dortmund, Germany.
Key Executives for CellAct Pharma GmbH
Similar Private Companies By Industry
|4 Animals AlsterScience GmbH||Europe|
|Across Barriers GmbH||Europe|
|Actinodrug Pharmaceuticals GmbH||Europe|
|ACTIPAC Biosystems GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact CellAct Pharma GmbH, please visit www.cellact.eu. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.